COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,585 Articles (22,905 medRxiv, 8,680 bioRxiv)

Most recent first Previous |  Page 2345: Articles 23441-23450  | Next

Real-time Nowcasting and Forecasting of COVID-19 Dynamics in England: the first wave?
Birrell, P. J., Blake, J., van Leeuwen, E., PHE Joint Modelling Cell, , Gent, N., De Angelis, D.
10.1101/2020.08.24.20180737 — Posted: 2020-08-30
Silicon Nitride Inactivates SARS-CoV-2 in vitro
Lehman, C. W., Flur, R., Kehn-Hall, K., McEntire, B. J., Bal, B. S., Bock, R. M.
10.1101/2020.08.29.271015 — Posted: 2020-08-29
Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms
Laurent, E. M., Sofianatos, Y., Komarova, A., Gimeno, J.-P., Samavarchi Tehrani, P., Kim, D.-K., Abdouni, H., Duhamel, M., Cassonnet, P., Knapp, J. J., Kuang, D., Chawla, A., Sheykhkarimli, D., Rayhan, A., Li, R., Pogoutse, O., Hill, D. E., Calderwood, M. E., Falter-Braun, P., Aloy, P., Stelzl, U., Vidal, M., Gingras, A.-C., Pavlopoulos, G. A., Van Der Werf, S., Fournier, I., Roth, F. P., Salzet, M., Demeret, C., Jacob, Y., Coyaud, E.
10.1101/2020.08.28.272955 — Posted: 2020-08-29 Discussion: Onsite
Establishment of murine hybridoma cells producing antibodies against spike protein of SARS-CoV-2
Antipova, N. V., Larionova, T. D., Shakhparonov, M. I., Pavlyukov, M. S.
10.1101/2020.08.29.272963 — Posted: 2020-08-29
Single-cell analysis of human trophoblast stem cell specification reveals activation of fetal cytotrophoblast expression programs including coronavirus associated host factors and human endogenous retroviruses
Tietze, E., Barbosa, A. R., Euclydes, V., Cho, H. J., Lee, Y. K., Feltrin, A., Leemput, J. v. d., Carlo, P. D., Sawada, T., Benjamin, K. J., Brentani, H., Kleinman, J. E., Hyde, T. M., Weinberger, D. A., Ursini, G., McKay, R., Paquola, A. C. M., Shin, J. H., Erwin, J. A.
10.1101/2020.08.29.273425 — Posted: 2020-08-29
The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans.
Pancer, K., Milewska, A., Owczarek, K., Dabrowska, A., Branicki, W., Sanak, M., Pyrc, K.
10.1101/2020.08.29.257360 — Posted: 2020-08-29
A simplified cell-based assay to identify coronavirus 3CL protease inhibitors
Resnick, S. J., Iketani, S., Hong, S. J., Zask, A., Liu, H., Kim, S., Melore, S., Nair, M. S., Huang, Y., Tay, N. E. S., Rovis, T., Yang, H. W., Stockwell, B. R., Ho, D. D., Chavez, A.
10.1101/2020.08.29.272864 — Posted: 2020-08-29
Universal properties of the dynamics of the Covid-19 pandemics
Chrusciel, P. T., Szybka, S. J.
10.1101/2020.08.24.20181214 — Posted: 2020-08-29
Real-time, interactive website for US-county level Covid-19 event risk assessment
Chande, A., Lee, S., Harris, M., Hilley, T., Andris, C., Weitz, J. S.
10.1101/2020.08.24.20181271 — Posted: 2020-08-29
Where do Brazilian dental students seek information about COVID-19?
Brito Aragao, M. G., Fernandes Gomes, F. I., Siqueira Silva Coelho, C., Pinho Maia Paixao de Melo, L., Milori Corona, S. A.
10.1101/2020.08.24.20179614 — Posted: 2020-08-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).